As in the PDAC context, where MYC directly activates the transcription of the pro‐death BCL2 family member NOXA (PMAIP1) [52] upon bortezomib treatment, NOXA contributes also in neuroblastoma models significantly to the bortezomib‐induced apoptosis [84]. This evidence concerns the gene BCL2 and neuroblastoma.